Summary
- Current Price
- As of today, CMMB price is $1.86, up +20.00% on
- Current Price All-Time High
- CMMB price is currently -99.75% below its historical high of $736.00 set on
- Market Cap
- CMMB current market cap is $11M, down -62.52% year-over-year
- PE Ratio
- CMMB PE ratio is unknown
- Revenue
- CMMB current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for CMMB has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Chemomab Therapeutics Ltd. |
| Ticker | NASDAQ: CMMB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Israel |
| IPO | |
| Indexes | Not included |
| Website | chemomab.com |
| Employees | 20 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.86 | ||
| Price, 1D Change | +20.00% | |
| $11M | ||
| - | ||
| - | ||
| 0.84 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.12 | ||
| EPS, 1Y Change | -51.84% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:4 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ANCN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.12 | ||
| EPS Estimate | N/A | -$0.08 |
| EPS Est. Change | N/A | +97.44% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $1.86 | ||
| Price Target | - | $17.50 |
| Price Tgt. Change | - | +840.86% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.07 | -$2.06 | -2,837.29% | |
| -$0.05 | -$3.12 | -6,143.80% | |
| -$0.08 | N/A | +97.44% | |
| -$0.20 | N/A | +93.59% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -71.30% | ||
| -72.81% | ||
| -62.52% | ||
| -39.41% | ||
| 0.00% | ||
| 0.00% | ||
| -51.84% | ||
| -159.99% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.86 | ||
| $3.20 | ||
| SMA 200 vs Price | +71.91% | |
| $1.70 | ||
| SMA 50 vs Price | -8.74% | |
| 0.84 | ||
| $0.17 | ||
| 60.21 | ||
| 126.31% | ||
| 73.17% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$3.12 | ||
| -$53.30K | ||
| - | ||
| -$14.81M | ||
| - | ||
| -$14.01M | ||
| - | ||
| -$14.76M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 4.98 | ||
| 4.98 | ||
| - | ||
| - | ||
| -8.44 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.02 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $13.54M | ||
| $14.34M | ||
| $16.96M | ||
| $16.04M | ||
| $3.43M | ||
| $3.22M | ||
| $324.00K | ||
| $115.00K | ||
| $666.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $14.01M | ||
| $14.76M | ||
| $53.30K | ||
| $0.00 | ||
| $53.30K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$15.46M | ||
| $2.31M | ||
| $9.91M | ||
| $0.00 | ||
| -$15.46M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Oppenheimer | → | |
| Oppenheimer | → | |
| Maxim Group | → | |
| Oppenheimer | → | |
| Maxim Group | ||
| Oppenheimer | → | |
| Oppenheimer | → | |
| Roth MKM | ||
| Oppenheimer | → | |
| Oppenheimer |
Analyst sentiment
Institutional ownership
Screeners with CMMB
FAQ
What is the ticker symbol for Chemomab Therapeutics Ltd.?
The ticker symbol for Chemomab Therapeutics Ltd. is NASDAQ:CMMB
Does Chemomab Therapeutics Ltd. pay dividends?
No, Chemomab Therapeutics Ltd. does not pay dividends
What sector is Chemomab Therapeutics Ltd. in?
Chemomab Therapeutics Ltd. is in the Healthcare sector
What industry is Chemomab Therapeutics Ltd. in?
Chemomab Therapeutics Ltd. is in the Biotechnology industry
What country is Chemomab Therapeutics Ltd. based in?
Chemomab Therapeutics Ltd. is headquartered in Israel
When did Chemomab Therapeutics Ltd. go public?
Chemomab Therapeutics Ltd. initial public offering (IPO) was on February 12, 2019
Is Chemomab Therapeutics Ltd. in the S&P 500?
No, Chemomab Therapeutics Ltd. is not included in the S&P 500 index
Is Chemomab Therapeutics Ltd. in the NASDAQ 100?
No, Chemomab Therapeutics Ltd. is not included in the NASDAQ 100 index
Is Chemomab Therapeutics Ltd. in the Dow Jones?
No, Chemomab Therapeutics Ltd. is not included in the Dow Jones index
When was Chemomab Therapeutics Ltd. last earnings report?
Chemomab Therapeutics Ltd.'s most recent earnings report was on November 10, 2022
When does Chemomab Therapeutics Ltd. report earnings?
The date for Chemomab Therapeutics Ltd.'s next earnings report has not been announced yet
Data Sources & References
- CMMB Official Website www.chemomab.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1534248/000117891325001205/0001178913-25-001205-index.htm
- CMMB Profile on Yahoo Finance finance.yahoo.com/quote/CMMB
- CMMB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cmmb